GSK plc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? GSK plc trades at $52.85 (market cap $101.34B), while iShares 10 20 Year Treasury Bond ETF trades at $98.43. The key difference: GSK plc pays a 3.49% dividend while iShares 10 20 Year Treasury Bond ETF pays none, and GSK plc is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| GSK | TLH | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | Fixed Income |
52-Week High | $61.18 | $105.36 |
52-Week Low | $36.20 | $97.13 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLH trades at $98.405, up 0.2% on the day, with technical indicators showing a bearish trend overall despite oversold RSI readings. The stock faces resistance near $99 and support at $98. Recent dividends include H1-26 at $0.41 and H2-26 at $0.36, but key valuation and profitability ratios are unavailable, limiting fundamental clarity.
The outlook is cautious due to bearish technical signals and missing financial metrics. Risks include market volatility from geopolitical tensions and Federal Reserve uncertainty. Investors should await updated earnings reports for a clearer fundamental picture before considering a position.
Trailing returns across standard periods
Latest headlines on both assets
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →